Biotech · Private company
Edesa Biotech Inc.
Track this companyFree. Adds Edesa Biotech Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials64 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- SOC plus 15mg/kg EB05 IVPhase 3 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- EB01 Cream 0.2%Phase 2 · Allergic Contact DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- EB01 Cream 1.0%Phase 2 · Allergic Contact DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- EB01 Cream 2.0%Phase 2 · Allergic Contact DermatitisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: BevacizumabPHASE2 · RECRUITING · started Oct 28, 2025ClinicalTrials.gov NCT06701656 · fetched Nov 12, 2026
- JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: VilobelimabPHASE2 · RECRUITING · started Jun 21, 2025ClinicalTrials.gov NCT06701682 · fetched Nov 12, 2026
- JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: ParidiprubartPHASE2 · RECRUITING · started Jun 10, 2025ClinicalTrials.gov NCT06701669 · fetched Nov 12, 2026
- JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)PHASE2 · RECRUITING · started Jun 10, 2025ClinicalTrials.gov NCT06703073 · fetched Nov 12, 2026
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With COVID-19PHASE2_PHASE3 · TERMINATED · started Nov 25, 2020ClinicalTrials.gov NCT04401475 · fetched Nov 12, 2026
- Evaluation of EB01 Cream for the Treatment of Chronic Allergic Contact DermatitisPHASE2 · COMPLETED · started Oct 15, 2019ClinicalTrials.gov NCT03680131 · fetched Nov 12, 2026